FDA accepts ChemoCentryx's avacopan application for blood vessel inflammation CCXI
#124460
Re: Farmas USA
PSNL
Personalis (NASDAQ:PSNL)has announced that the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP) has exercised its option to extend its existing contract through September 2021.
The VA also issued a new task order with of up to $31M, and it has the right to issue additional task orders through the duration of the contract extension. The cumulative value of task orders received to date from the VA MVP has increased to ~$175M.
“New orders from our biopharma and other customers have also continued to be strong. Year to date, those orders are almost double the level received in the first three quarters of 2019. Orders from all of our customers, taken together, are significantly above the levels received during the first three quarters of 2019.” said John West, CEO.
